Disease Progression

Progression of PD symptomatology varies, and different patterns of symptom presentation and progression have suggested the existence of subtypes of disease.  The identification of biomarkers of disease progression is the subject of intense investigation, as the discovery of such markers would greatly facilitate therapeutics development.

Observation of patterns in the progression of PD histopathology has lead to the hypothesis that PD follows a characteristic staging pattern. The classic histological hallmark of PD is the presence of fibrillar aggregates called Lewy bodies in brain and other tissues. While in advanced stages of illness PD pathology can be widespread in the brain, it is concentrated in certain areas of selective vulnerability.

The Braak hypothesis suggests that PD pathology begins with an infectious assault in the enteric nervous system and slowly progresses rostrally toward the brainstem, midbrain and cortical regions and also that histological evidence of PD can be observed in certain neuronal and non-neuronal tissues far in advance of the presentation of cardinal motor symptoms. Given that a similar progression of clinical symptoms can occur, there has been some attention focused on the Braak hypothesis, though it is unclear whether the observed progression may be initiated by a regional pathogen or may instead reflect a pattern of selective neuronal susceptibility to other factors (Braak and Del Tredici, 2008).

 

17 Dec 2009
A recent article describes an MRI study evaluating atrophic changes in olfactory-related brain regions using voxel-based morphometry (VBM).  Early and moderately advanced PD patients and healthy ... 
Hot Topics@SfN 2009
20 Oct 2009
To date, all clinical trials have been performed in relatively advanced PD patients where the status of the residual nigrostriatal system has been poorly characterized.  ... 
Responses: 1
Hot Topics@SfN 2009
19 Oct 2009
In poster 429.3, Lotz et al. describe a new effort at examining the stability of hyperechogenicity in substantia nigra of people with PD, which is measured non-invasively with ultrasound via the ... 
Responses: 4
11 Aug 2009
There are a number of imaging methodologies that have been used to study motor and non-motor features of PD including PET, SPECT, MRI, fMRI, and  DTI.  These techniques have been used both ... 
Responses: 9
10 Jun 2009
This group aims to promote interactions, collaborations and the exchange of ideas of those members interested in developing or characterizing genetic disease models, particularly mouse models. ... 
22 Apr 2007
The main goal of the GENEPARK consortium is to employ innovative haemogenomic approaches to determine gene expression profiles specific for genetic and idiopathic Parkinson's disease (PD) patients. ... 
19 Mar 2007
The purpose of this trial is to determine if the nutritional supplement creatine slows the progression of Parkinson's disease over time. ... 
29 Nov 2006
This study will investigate the effect of TCH346 compared to placebo in delaying the need for symptomatic treatment with dopaminergic agents ...